MedPointe gears up for product acquisitions
Executive Summary
MedPointe will use $70 mil. from sale of Wampole diagnostics division to acquire additional pharmaceutical products. The company is considering respiratory and pediatric products with annual sales of $30 mil. to $100 mil. to complement its existing portfolio; one or more deals could be announced by the end of the year. MedPointe, lead by former Warner-Lambert exec Anthony Wild, acquired Wampole when it purchased Carter-Wallace's healthcare business in October 2001 (1"The Pink Sheet" May 14, 2001, p. 13). The cash sale of Wampole to Inverness is expected to close in September...